MCMichelle Icka Christensen

Michelle Icka Christensen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Michelle Icka Christensen has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Avoidance Versus Use of Neuromuscular Blocking Agents for Optimising Video Laryngoscopy‐Assisted Tracheal Intubation—A Systematic Review With Meta‐Analysis and Trial Sequential Analysis

    by Andreas Creutzburg, Emil Ørskov Ipsen, Lars Hyldborg Lundstrøm, Michelle Icka Christensen, Arash Afshari, Louise Bill, Helene Korvenius Nedergaard, Matias Vested, Anders Kehlet Nørskov

    Background: Tracheal intubation during anaesthesia carries risks, and difficult intubation can lead to severe complications. Neuromuscular blocking agents (NMBAs) are widely recommended to improve intubation conditions, but they have potential adverse effects. Video laryngoscopy is widely used, yet evidence on the role of NMBAs in this setting is sparse. We aimed to assess whether avoidance versus use of NMBAs affects first‐pass success and intubation conditions during video laryngoscopy in adults. Method: Randomised controlled trials ( RCTs ) comparing avoidance versus use of NMBAs for tracheal intubation in adults during video laryngoscopy were included. The primary outcome was failed first‐pass intubation, as defined by the individual trials. Secondary outcomes were failed intubation, adverse effects ( AEs ) and serious adverse effects ( SAEs ), and acceptable intubation conditions. Furthermore, trial sequential analysis ( TSA ) was undertaken. Results: 9483 records were screened. Eight RCTs (744 participants) met the inclusion criteria. The primary outcome was extractable from seven trials (690 participants). Individual trial estimates showed either no clear effect or an increased risk of failed first‐pass intubation when NMBAs were avoided. We found a statistically non‐significant RR: 1.81 (95% CI: 0.93–3.55, p = 0.08, Cochran's Q = 12.0, p = 0.04, I 2 = 58%, D 2 = 74%, TSA adjusted RR: 1.77, TSA adjusted 95% CI: 0.48–6.50, GRADE = very low certainty of evidence) comparing avoidance versus use of NMBAs. TSA showed that the trial sequential monitoring boundaries were not crossed, and the required information size of 2334 was not achieved. Conclusion: The effect of avoidance of NMBAs for facilitating video laryngoscopy‐assisted tracheal intubation in adult patients is uncertain (very low certainty), and the required information size was not reached. Editorial Comment: This systematic review assessed trial evidence concerning whether or not muscle relaxant use is related to first pass failure in intubation attempts using video laryngoscopy. Evidence to date does not support a clear conclusion on whether avoidance of muscle relaxants in this context is beneficial or not, at least for first pass intubation success, though the evidence has very low certainty for this question.

  • Open Access

    Occurrence of Hypoxemia the First Day After Trauma Assessed by Continuous Pulse Oximetry

    by Jacob Jensen‐Abbew, Emma Atsuko Tsuchiya, Tobias Arleth, Felicia Dinesen, Carl Johan Queitsch, Martin Von Magius, Michelle Icka Christensen, Karl Peter Damgård Madsen, Oscar Rosenkrantz, Jacob Steinmetz

    Background: Trauma is a leading cause of death and disability in young adults. Although supplemental oxygen is recommended early after trauma to prevent hypoxemia, evidence regarding the occurrence and distribution of hypoxemic episodes, to raise awareness on potential clinical implications, is sparse. The aim of this study was to investigate the occurrence and daily distribution of hypoxemia within the first day of admission after trauma using continuous pulse oximetry. Methods: Adult trauma patients admitted through the trauma centre at Rigshospitalet, Denmark, between February 20 and August 24, 2024, were included in this observational study irrespective of subsequent admission department. Arterial oxygen saturation measured by pulse oximetry (SpO 2 ) was continuously monitored for 24 h to identify clinically relevant hypoxemic episodes, defined as SpO 2 < 90%, for > 5 min. The incidence of episodes was compared regarding the occurrence between daytime and nighttime. Hypoxemic episodes were hypothesized to be more frequent during nighttime. Results: Among 165 included participants, data from 155 were analyzed. Median age was 49 years (IQR 31–62), 74.8% were male, and median Injury Severity Score was 13 (IQR 9–19). In total 146 episodes were recorded, and both daytime and nighttime periods showed incidence rates of 5.1 episodes per 100 participant‐hours, yielding an incidence rate ratio (IRR) of 1.01 (95% CI, 0.73–1.4; p = 0.95) between daytime and nighttime. No differences between daytime and nighttime were found in cumulative hypoxemia duration, prolonged hypoxemic episodes, or across hospital locations. Conclusion: On average, 5.1 clinically relevant hypoxemic episodes occurred per 100 participant‐hours of continuous SpO 2 monitoring during the first 24 h of hospitalization following trauma. The study found similar incidence rates of clinically relevant hypoxemic episodes at daytime and nighttime. Editorial Comment: Supplementary oxygen is recommended in the early phase after trauma to prevent hypoxaemia. This single center study confirmed that clinically relevant hypoxaemic episodes occur on average five times per 100 participant‐hours during the first 24 h of hospitalization following trauma, with similar incidences during both day and night. The study highligths the importance of continuous monitoring of peripheral oxygenation including if trauma patients are transferred from high‐depency units to the wards. Trial Registration: ClinicalTrials.gov : NCT06256692

  • Open Access

    Avoidance versus use of neuromuscular blocking agents for optimizing video laryngoscopy‐assisted tracheal intubation: A protocol for a systematic review with meta‐analysis and trial sequential analysis

    by Andreas Creutzburg, Anders Kehlet Nørskov, Michelle Icka Christensen, Arash Afshari, Lars Hyldborg Lundstrøm, Louise Bill, Helene Korvenius Nedergaard, Matias Vested

    Background: Both the European Society of Anaesthesiology and Intensive Care and the Difficult Airway Society recommend the use of neuromuscular blocking agents (NMBAs) to facilitate tracheal intubation and to reduce the risk of complications. Even though it is recommended to use video laryngoscopy for intubation, especially in circumstances where difficult tracheal intubation is expected, the evidence for the combination of video laryngoscopy and NMBAs is sparse. This protocol outlines a systematic review of the effect of avoidance versus use of NMBAs for tracheal intubation during video laryngoscopy in adults.Methods: This protocol is made in accordance with reporting items for systematic reviews and meta‐analyses protocols recommendations. We intent to include randomised controlled trials assessing the effect of avoidance versus use of NMBAs during video laryngoscopy to facilitate tracheal intubation (either nasal or oral) in the adult population. The primary outcome is failed first‐pass intubation. Our secondary outcomes include adverse and serious adverse events. A thorough search will be done to identify relevant trials, including CENTRAL, MEDLINE, EMBASE, BIOSIS, Web of Science and CIHNAL. Furthermore, trial registries will be searched for unpublished trials. Each trial will be evaluated for bias. We will use appropriate packages in R to perform the meta‐analysis. Additionally, we will perform trial sequential analysis on the meta‐analysis of our primary outcome. Lastly, we will employ the GRADE approach and create “Summary of Findings” tables.


  • Open Access

    Effects of avoidance versus use of neuromuscular blocking agents for facilitation of tracheal intubation in children and infants: a protocol for a systematic review, meta‐analysis and trial sequential analysis

    by Michelle Icka Christensen, Matias Vested, Andreas Creutzburg, Anders Kehlet Nørskov, Lars Hyldborg Lundstrøm, Arash Afshari

    Background: The European Society of Anesthesiology and Intensive Care recommends the use of neuromuscular blocking agents (NMBA) in adults, to facilitate tracheal intubation and reduce its associated complications. Children who undergo tracheal intubation may suffer some of the same complications, however, no consensus exists regarding the use of NMBA for tracheal intubation in the pediatric population.We will explore the existing evidence assessing the effects of avoidance versus the use of NMBA for the facilitation of tracheal intubation in children and infants.Methods: This protocol follows the preferred reporting items for systematic reviews and meta‐analyses protocols recommendations. We will include all randomized controlled clinical trials assessing the effects of avoidance versus the use of NMBA for facilitation of tracheal intubation (oral or nasal) using direct laryngoscopy or video laryngoscopy in pediatric participants (<18 years). Our primary outcome is incidence of difficult tracheal intubation. Secondary outcomes include incidence of serious adverse events, failed intubation, events of upper airway discomfort or injury, and difficult laryngoscopy.We will conduct a thorough database search to identify relevant trials, including CENTRAL, MEDLINE, EMBASE, BIOSIS, Web of Science, CINAHL, and trial registries. Two review authors will independently handle the screening of literature and data extraction. Each trial will be evaluated for major sources of bias with the “classic risk of bias tool” used in the Cochrane Collaboration tool from 2011. We will use Review manager (RevMan) or R with the meta package to perform the meta‐analysis. We will perform a trial sequential analysis on the meta‐analysis of our primary outcome, providing an estimate of statistical reliability.Two review authors will independently assess the quality of the body of evidence using the grading of recommendations assessment, development, and evaluation (GRADE) approach. We will use GRADEpro software to conduct the GRADE assessments and to create “Summary of the findings” tables.